Primary adrenal insufficiency in the United States: diagnostic error and patient satisfaction with treatment
Autor: | Anand Vaidya, Elizabeth A. Regan, Barry J. Make, Paul L Margulies, James D. Crapo, Katherine E Lowe |
---|---|
Rok vydání: | 2019 |
Předmět: |
Adult
Male Pediatrics medicine.medical_specialty Hydrocortisone Clinical Biochemistry Medicine (miscellaneous) 030209 endocrinology & metabolism Comorbidity Health Services Accessibility Autoimmune Diseases Primary Adrenal Insufficiency 03 medical and health sciences Patient safety 0302 clinical medicine Patient satisfaction Addison Disease Clinical Protocols Ethnicity medicine Adrenal insufficiency Humans Registries 030212 general & internal medicine Diagnostic Errors Glucocorticoids Aged business.industry Health Policy Biochemistry (medical) Public Health Environmental and Occupational Health Disease Management Adrenal crisis Middle Aged medicine.disease Thyroid Diseases United States Cross-Sectional Studies Patient Satisfaction Addison's disease Cohort Female medicine.symptom business medicine.drug |
Zdroj: | Diagnosis. 6:343-350 |
ISSN: | 2194-802X 2194-8011 |
DOI: | 10.1515/dx-2019-0013 |
Popis: | Background The objective of the study was to assess the diagnostic process, access to care and treatment adequacy for primary adrenal insufficiency (PAI) patients from a US-based online registry. Methods The National Adrenal Diseases Foundation (NADF) patient registry from 2015 to 2016 was used for a cross-sectional assessment of PAI patients. Five hundred and forty-one adults met the study inclusion criteria (US residents, age >20, self-reported physician diagnosis of PAI and replacement dosing for cortisol). Issues in diagnosis, comorbid conditions, symptoms, with demographic and socioeconomic characteristics were determined. Disease management assessment included medication dose, patient satisfaction with function, and education. Factors associated with adrenal crisis were noted. Results The cohort was predominantly female (83%), non-Hispanic White (97%), and well-educated (94% > high school education). A majority (57%) of patients reported difficulty with initial diagnosis, while 27% felt that their current steroid replacement was not adequate. Comorbid thyroid disease and other autoimmune conditions were common among PAI patients in the registry. More than three-quarters (78%) of patients used hydrocortisone for glucocorticoid replacement with a mean dose of 24.4 (standard deviation [SD]: 8.7) mg. Mean dose of hydrocortisone has declined over time following current treatment recommendations. Conclusions Timely, accurate diagnosis remains a problem for patients with primary adrenal insufficiency in an affluent, well-educated US cohort. Episodes of adrenal crisis are common and replacement steroid treatment is not always effective for patient function. Comprehensive information about outcomes of care for PAI in the US remains limited and the establishment of a research-specific registry to foster future research may be desirable. Patient registry data is a valuable source of information on diagnostic error and outcomes of care in rare diseases. |
Databáze: | OpenAIRE |
Externí odkaz: |